European Heart Journal Advance Access published online on February 15, 2005
European Heart Journal, doi:10.1093/eurheartj/ehi126
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Hôpital Européen Georges Pompidou, 20 rue Leblanc, 75015 Paris, France
* To whom correspondence should be addressed.
Editorial
Percutaneous coronary intervention following intravenous fibrinolytic therapy: should it be a must?
Nicolas Danchin, E-mail: nicolas.danchin{at}egp.ap-hop-paris.fr
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
F. Osman, S. Qaisar, and N. El Gaylani Limitations of the study evaluating fibrinolytic therapy and in-hospital PCI for ST-elevation myocardial infarction Eur. Heart J., August 2, 2005; 26(16): 1684 - 1684. [Full Text] [PDF] |
||||
![]() |
A.A. J. Adgey and A. J.J. McClelland Percutaneous coronary intervention and 1-year survival in patients treated with fibrinolytic therapy for acute ST-elevation myocardial infarction: reply Eur. Heart J., August 2, 2005; 26(16): 1684 - 1685. [Full Text] [PDF] |
||||
